Ibis Capital Partners is an investment banking firm focused on M&A advisory, management consulting.
Ibis Capital Partners is an investment banking firm focused on M&A advisory, management consulting.
Announced Date | Fund Name | Money Raised | |
---|---|---|---|
Apr 3, 2017 | OS Investment | ¥10B | |
Oct 31, 2016 | Ibis New Growth Fund IV | - | |
Jun 30, 2014 | Ibis New Growth Fund II | - | |
May 31, 2013 | Ibis Support Investment Fund | - | |
May 31, 2013 | Ibis New Growth Investment Fund | - |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Feb 18, 2020
YAMATO
|
Series Unknown | — | Artificial Intelligence | — |
Feb 18, 2020
Yamato Holdings
|
Post-IPO Equity | — | Delivery Service | Yes |
Nov 18, 2019
Standard Capital
|
Seed | ¥3.28B | Business Intelligence | — |
May 22, 2018
A.L.I. Technologies Japan
|
Series Unknown | ¥88.75M | Aerospace | — |
Nov 28, 2017
AI CROSS
|
Series Unknown | ¥300M | Artificial Intelligence | — |
Ibis Capital Partners has had 2 exits. Ibis Capital Partners most notable exits include AI CROSS , BrightPath Biotherapeutics
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Oct 8, 2019 | AI CROSS | IPO | Artificial Intelligence | Detail |
Oct 22, 2015 | BrightPath Biotherapeutics | IPO | Biotechnology | Detail |